CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA) Inc.

1:16-cv-01120

Overview

Case Number 1:16-cv-01120
Filing Date 2016-12-05
Status Terminated
Termination Date 2019-05-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hikma Pharmaceuticals International Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Kathleen Y. Kim

Email: kykim@winston.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Hikma Labs, Inc. Operating Company

Represented By

6 Attorneys Listed

Zachary L. Sorman

UNDELIVERABLE EMAIL 7/31/2020

Samuel S. Park

UNDELIVERABLE EMAIL 10/31/2018

Kathleen Y. Kim

Email: kykim@winston.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Charles B. Klein

Email: cklein@winston.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Hikma Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

Zachary L. Sorman

UNDELIVERABLE EMAIL 7/31/2020

Samuel S. Park

UNDELIVERABLE EMAIL 10/31/2018

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Charles B. Klein

Email: cklein@winston.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

West-Ward Pharmaceuticals International Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Kathleen Y. Kim

Email: kykim@winston.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

West-Ward Pharmaceuticals Corp. Operating Company

Represented By

3 Attorneys Listed

Kathleen Y. Kim

Email: kykim@winston.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Roxane Laboratories, Inc. Operating Company

Represented By

7 Attorneys Listed

Zachary L. Sorman

UNDELIVERABLE EMAIL 7/31/2020

Sharick Naqi

UNDELIVERABLE EMAIL 4/17/2018

Samuel S. Park

UNDELIVERABLE EMAIL 10/31/2018

Kathleen Y. Kim

Email: kykim@winston.com

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Charles B. Klein

Email: cklein@winston.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Cadila Healthcare Ltd. Operating Company

Represented By

2 Attorneys Listed

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Zydus Pharmaceuticals (USA) Inc. Operating Company

Represented By

7 Attorneys Listed

Timothy F. Peterson

Email: tpeterson@lockelord.com

Michael J. Gaertner

Email: mgaertner@lockelord.com

Jennifer M. Coronel

Email: jennifer.coronel@lockelord.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

David B. Abramowitz

Email: dabramowitz@lockelord.com

Andy J. Miller

UNDELIVERABLE EMAIL 5/2/2020

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Apotex Corp. Operating Company

Represented By

5 Attorneys Listed

Lance A. Soderstrom

Email: lance.soderstrom@katten.com

Joseph M. Janusz

Email: joe.janusz@kattenlaw.com

Deepro R. Mukerjee

Email: deepro.mukerjee@katten.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Alissa M. Pacchioli

UNDELIVERABLE EMAIL 6/7/2021

Apotex Inc. Operating Company

Represented By

5 Attorneys Listed

Lance A. Soderstrom

Email: lance.soderstrom@katten.com

Joseph M. Janusz

Email: joe.janusz@kattenlaw.com

Deepro R. Mukerjee

Email: deepro.mukerjee@katten.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Alissa M. Pacchioli

UNDELIVERABLE EMAIL 6/7/2021

Actavis LLC Operating Company

Represented By

4 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

J. Anthony Downs

Email: jdowns@goodwinlaw.com

Steven J. Bernstein

Email: sbernstein@goodwinlaw.com

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Medivation, Inc. Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

The Regents of the University of California NPE (University / Research)

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

Medivation Prostate Therapeutics LLC Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Medivation LLC Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Medivation Prostate Therapeutics, Inc. Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Astellas Pharma US, Inc. Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Astellas US LLC Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Astellas Pharma Inc. Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Actavis Laboratories FL, Inc. Operating Company

Represented By

7 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

J. Anthony Downs

Email: jdowns@goodwinlaw.com

Steven J. Bernstein

Email: sbernstein@goodwinlaw.com

Nathan Roger Hoeschen

Shaw Keller LLP

Tel: +1 (302) 298-0709

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Elaine H. Blais

Email: eblais@goodwinlaw.com

Cynthia L Hardman

UNDELIVERABLE EMAIL 4/10/2019

Andrew E. Riley

Email: ariley@goodwinlaw.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7709517
Diarylhydantoin compounds
Filed: 2006-05-15
Issued: 2010-05-04
Active (0.7 yrs remaining) +455d PTA
Expires: 2027-08-13
US8183274
Treatment of hyperproliferative disorders with diarylhydantoin compounds
Filed: 2010-02-18
Issued: 2012-05-22
Expired (Term Ended)
Expires: 2026-08-24
US9126941
Treatment of hyperproliferative disorders with diarylhydantoin compounds
Filed: 2012-04-17
Issued: 2015-09-08
Active (5.4 yrs remaining)
Expires: 2032-04-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+455 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

7

Dispositive

0

Granted

0

Denied

0

Pending / Review

7

Motions by Category

Procedural / Extension Motion 7

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to July 7, 2017 - filed by Astellas Pharma Inc., Astellas Pharma US, Inc....
Entry #34 • 2017-06-19 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 19, 2017 - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Ast...
Entry #29 • 2017-06-05 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 5, 2017 - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Aste...
Entry #28 • 2017-05-22 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to May 22, 2017 - filed by Astellas Pharma Inc., Astellas Pharma US, Inc., Aste...
Entry #23 • 2017-05-08 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a joint status report and proposed scheduling order to the Court to April 5, 2017 - filed by Astellas Pharm...
Entry #17 • 2017-03-29 Document →
Procedural / Extension Motion Pending / Under Review
SO ORDERED - re 8 STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the Complaint to February 27, 2017 filed by Actavis LLC...
Entry #9 • 2016-12-15 Document →

Docket Entries

(43 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis LLC, Actavis Laboratories FL, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2039619.) - filed by Astellas Pharma US, Inc., Astellas Pharma Inc., Astellas US LLC, Medivation Prostate Therapeutics, Inc., Medivation, Inc., The Regents of the University of California. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(jcs) (Entered: 12/05/2016)

Entry #1 • 2016-12-02
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis LLC, Actavis Laboratories FL, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2039619.) - filed by Astellas Pharma US, Inc., Astellas Pharma Inc., Astellas US LLC, Medivation Prostate Therapeutics, Inc., Medivation, Inc., The Regents of the University of California. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(jcs) (Entered: 12/05/2016)

Entry #1 • 2016-12-02
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis LLC, Actavis Laboratories FL, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2039619.) - filed by Astellas Pharma US, Inc., Astellas Pharma Inc., Astellas US LLC, Medivation Prostate Therapeutics, Inc., Medivation, Inc., The Regents of the University of California. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(jcs) (Entered: 12/05/2016)

Entry #1 • 2016-12-02
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 12/05/2016)

Entry #2 • 2016-12-02
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/25/2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/29/2020. (jcs) (Entered: 12/05/2016)

Entry #3 • 2016-12-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc